Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Chung

Showing results (151-160 of 237) with videos related to

Pageof 24
Sort By:
Urologic Oncology|April 8, 2022
The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancerLouise C McLoughlin, Sophie O'Halloran, Michael Tjong, et al.
Technical Innovations & Patient Support in Radiation Oncology|June 2, 2023
Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapyWinnie Li, Jerusha Padayachee, Inmaculada Navarro, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2005
A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapyAlan Nichol, Peter Chung, Gina Lockwood, et al.
Urologic Oncology|April 4, 2026
Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable diseaseAhmad Mousa, James Hayes, Ali Amiri, et al.
Brachytherapy|December 22, 2022
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancerNoelia Sanmamed, Lisa Joseph, Juanita Crook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2019
Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on SurveillanceRobert J Hamilton, Madhur Nayan, Lynn Anson-Cartwright, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Pathological predictors for site of local recurrence after radiotherapy for prostate cancerSupriya Chopra, Ants Toi, Nathan Taback, et al.
BJU International|July 5, 2024
Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapyAhmad Mousa, Lynn Anson-Cartwright, Eshetu G Atenafu, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|July 26, 2023
Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer NetworkPiero Bettoli, ZhihuiAmy Liu, Natalia Jara, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 15, 2019
Canadian Urological Association guideline: Muscle-invasive bladder cancerGirish S Kulkarni, Peter C Black, Srikala S Sridhar, et al.
Pageof 24

Showing results (151-160 of 237) with videos related to

Sort By:
Pageof 24
Urologic Oncology|April 8, 2022
The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancerLouise C McLoughlin, Sophie O'Halloran, Michael Tjong, et al.
Technical Innovations & Patient Support in Radiation Oncology|June 2, 2023
Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapyWinnie Li, Jerusha Padayachee, Inmaculada Navarro, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2005
A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapyAlan Nichol, Peter Chung, Gina Lockwood, et al.
Urologic Oncology|April 4, 2026
Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable diseaseAhmad Mousa, James Hayes, Ali Amiri, et al.
Brachytherapy|December 22, 2022
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancerNoelia Sanmamed, Lisa Joseph, Juanita Crook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2019
Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on SurveillanceRobert J Hamilton, Madhur Nayan, Lynn Anson-Cartwright, et al.
International Journal of Radiation Oncology, Biology, Physics|January 31, 2012
Pathological predictors for site of local recurrence after radiotherapy for prostate cancerSupriya Chopra, Ants Toi, Nathan Taback, et al.
BJU International|July 5, 2024
Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapyAhmad Mousa, Lynn Anson-Cartwright, Eshetu G Atenafu, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|July 26, 2023
Primary Bladder Sarcoma: A multi-institutional experience from the Rare Cancer NetworkPiero Bettoli, ZhihuiAmy Liu, Natalia Jara, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 15, 2019
Canadian Urological Association guideline: Muscle-invasive bladder cancerGirish S Kulkarni, Peter C Black, Srikala S Sridhar, et al.
Pageof 24